These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10431168)

  • 1. Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections.
    Tümmler B; Kiewitz C
    Mol Med Today; 1999 Aug; 5(8):351-8. PubMed ID: 10431168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity of microbes associated with cystic fibrosis.
    Hutchison ML; Govan JR
    Microbes Infect; 1999 Oct; 1(12):1005-14. PubMed ID: 10617932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CFTR-dependent susceptibility of the cystic fibrosis-host to Pseudomonas aeruginosa.
    Grassmé H; Becker KA; Zhang Y; Gulbins E
    Int J Med Microbiol; 2010 Dec; 300(8):578-83. PubMed ID: 20951085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent and aggressive bacteria in the lungs of cystic fibrosis children.
    Hart CA; Winstanley C
    Br Med Bull; 2002; 61():81-96. PubMed ID: 11997300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary infections in patients with cystic fibrosis.
    Rajan S; Saiman L
    Semin Respir Infect; 2002 Mar; 17(1):47-56. PubMed ID: 11891518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis.
    Campodónico VL; Gadjeva M; Paradis-Bleau C; Uluer A; Pier GB
    Trends Mol Med; 2008 Mar; 14(3):120-33. PubMed ID: 18262467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis genotype and bacterial infection: a possible connection.
    McManus TE; Beattie D; Graham C; Moore JE; Elborn JS
    Br J Biomed Sci; 2005; 62(2):85-8. PubMed ID: 15997883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CFTR mutations and host susceptibility to Pseudomonas aeruginosa lung infection.
    Pier GB
    Curr Opin Microbiol; 2002 Feb; 5(1):81-6. PubMed ID: 11834374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part I: Isolated microorganisms and their clinical significance].
    Coman G; Petraru E; Dahorea C; Anton DT
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):580-7. PubMed ID: 23077957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
    Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B
    Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis and diagnosis of bacterial airway infections in patients with cystic fibrosis].
    Möller AV; van Alphen L; Dankert-Roelse JE; Dankert J
    Ned Tijdschr Geneeskd; 1995 Nov; 139(46):2346-9. PubMed ID: 7501072
    [No Abstract]   [Full Text] [Related]  

  • 13. [Isolated pathogen microorganisms in respiratory samples from children with cystic fibrosis].
    Anzaudo MM; Busquets NP; Ronchi S; Mayoral C
    Rev Argent Microbiol; 2005; 37(3):129-34. PubMed ID: 16323660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.
    Pier GB; Grout M; Zaidi TS; Olsen JC; Johnson LG; Yankaskas JR; Goldberg JB
    Science; 1996 Jan; 271(5245):64-7. PubMed ID: 8539601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and management of pulmonary infections in cystic fibrosis.
    Gibson RL; Burns JL; Ramsey BW
    Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CFTR protein susceptibility to bacterial infections in cystic fibrosis.
    Ramphal R
    Trends Microbiol; 2001 Feb; 9(2):63. PubMed ID: 11286194
    [No Abstract]   [Full Text] [Related]  

  • 17. Microbiology of airway disease in patients with cystic fibrosis.
    Gilligan PH
    Clin Microbiol Rev; 1991 Jan; 4(1):35-51. PubMed ID: 1900735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
    Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
    J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequencing of the Pseudomonas aeruginosa and Burkholderia cepacia genomes and their applications in relation to cystic fibrosis.
    Miller DA; Mahenthiralingam E
    J R Soc Med; 2003; 96 Suppl 43(Suppl 43):57-65. PubMed ID: 12906327
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.